Selenium metabolism, selenoproteins and mechanisms of cancer prevention: Complexities with thioredoxin reductase

Carcinogenesis

Volumn 20, Issue 9, 1999, Pages 1657-1666

  Ganther, Howard E ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL CYCLE PROTEIN; CYSTEINE; DISULFIDE; PROTEIN KINASE C; PROTEIN P53; SELENIUM; SELENOPROTEIN; THIOREDOXIN; THIOREDOXIN REDUCTASE; TRANSCRIPTION FACTOR;

APOPTOSIS; CANCER PREVENTION; CATALYSIS; CELL TRANSFORMATION; DIETARY INTAKE; DNA DAMAGE; ENZYME ACTIVITY; HUMAN; METABOLISM; METABOLITE; OXIDATIVE STRESS; PHENOTYPE; PRIORITY JOURNAL; REVIEW;

ANIMALS; ANTICARCINOGENIC AGENTS; APOPTOSIS; CELL CYCLE PROTEINS; CELL DIVISION; CYSTEINE; ENZYME INHIBITORS; GENE EXPRESSION REGULATION; HUMANS; METHYLATION; MICE; MOLECULAR WEIGHT; NEOPLASMS; NEOPLASMS, EXPERIMENTAL; OXIDATION-REDUCTION; PROTEIN KINASE C; PROTEINS; SELENIUM; SELENOCYSTEINE; SELENOPROTEINS; THIOREDOXIN; THIOREDOXIN REDUCTASE (NADPH); TRANSCRIPTION FACTORS;

EID: 0032848137     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/20.9.1657     Document Type: Review

References (86)

1. Ip, C. (1984) Selenium inhibition of chemical carcinogenesis. Fed. Proc., 44, 2573-2578.
2. Medina, D. and Morrison, D.G. (1988) Current ideas on selenium as a chemopreventive agent. Pathol. Immunopathol. Res., 7, 187-199.
3. El-Bayoumy, K. (1993) The role of selenium in cancer prevention. In DeVita, V.T. Jr, Hellman, S. and Rosenberg, S.A. (eds) Cancer: Principles and Practice of Oncology, 4th Edn. Lippincott, Philadelphia, PA, Vol. 2, pp. 1-15.
4. Combs, G.F. Jr and Gray, W.P. (1998) Chemopreventive agents: selenium. Pharmacol. Ther., 79, 179-192.
5. Ip, C. (1998) Lessons from basic research in selenium and cancer prevention. J. Nutr., 128, 1845-1854.
6. Clark, L.C., Combs, G.F. Jr, Turnbull, B.W. et al. (1996) Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin: a randomized controlled trial. J. Am. Med. Assoc., 276, 1957-1963.
7. Ganther, H.E. (1986) Pathways of selenium metabolism including respiratory excretory products. J. Am. Coll. Toxicol., 5, 1-5.
8. Ganther, H.E. and Lawrence, J.R. (1997) Chemical transformations of selenium in living organisms. Improved forms of selenium for cancer prevention. Tetrahedron, 53, 12229-12310.
9. Ganther, H.E. (1971) Reduction of the selenotrisulfide derivative of glutathione to a persulfide analog by glutathione reductase. Biochemistry, 10, 4089-4098.
10. Hsieh, H.S and Ganther, H.E. (1975) Acid-volatile selenium formation catalyzed by glutathione reductase. Biochemistry, 14, 1632-1636.
11. Bjornstedt, M., Kumar, S. and Holmgren, A. (1992) Selenodiglutathione is a highly efficient oxidant of reduced thioredoxin and a substrate for mammalian thioredoxin reductase. J. biol. Chem., 267, 8030-8034.
12. Veres, Z., Kim I.Y., Scholz, T.D. and Stadtman, T.C. (1994) Selenophosphate synthetase. Enzyme properties and catalytic action. J. Biol. Chem., 269, 10597-10603.
13. Gladyshev, V.N, Jeang, K.-T., Wootton, J.C. and Hatfield, D.L. (1998) A new human selenium-containing protein. J. Biol. Chem., 273, 8910-8915.
14. Zinoni, F., Birkman, A., Leinfelder, W. and Bock, A. (1987) Cotranslational insertion of selenocysteine into formate dehydrogenase from Escherichia coli directed by a UGA codon. Proc. Natl Acad. Sci. USA, 84, 3156-3160.
15. Stadtman, T.C. (1996) Selenocysteine. Annu. Rev. Biochem., 65, 83-100.
16. Uden, P.C., Bird, S.M., Kotrebai, M., Nolibos, P., Tyson, J.F., Block, E. and Denoyer, E. (1998) Analytical selenoaminoacid studies by chromatography with interfaced atomic mass spectrometry and atomic emission spectral detection. Fresenius J. Anal. Chem., 362, 447-456.
17. Neuhierl, B. and Bock, A. (1996) On the mechanism of selenium tolerance in selenium-accumulating plants. Purification and characterization of a specific selenocysteine methyltransferase from cultured cells of Astragulus bisculatus. Eur. J. Biochem., 239, 235-238.
18. Ip, C. and Ganther, H. (1990) Activity of methylated forms of selenium in cancer prevention. Cancer Res., 50, 1206-1211.
19. Ip, C., Hayes, C., Budnick, R.M. and Ganther, H.E. (1991) Chemical forms of selenium, critical metabolites and cancer prevention. Cancer Res., 51, 595-600.
20. Andreadou, I., Water, B., Commandeur, J.N.M., Worthington, E.A and Vermeulen, N.P.E. (1996) Comparative cytotoxicity of 14 novel selenocysteine Se-conjugates in rat renal proximal tubular cells. Toxicol. Appl. Pharmacol., 141, 278-287.
21. Wilson, A.C., Thompson, H.J., Schedin, P.J., Gibson, N.W. and Ganther, H.E. (1992) Effect of methylated forms of selenium on cell viability and the induction of DNA strand breakage. Biochem. Pharmacol., 43, 1137-1141.
22. Lu J., Jiang, C., Kaeck, M., Ganther, H., Vadhanavikit, S., Ip, C. and Thompson, H. (1995) Dissociation of the genotoxic and growth inhibitory effects of selenium. Biochem. Pharmacol., 50, 213-219.
23. Kaeck, M., Lu, J., Strange, R., Ip, C., Ganther, H.E. and Thompson, H.J. (1997) Differential induction of growth arrest inducible genes by selenium compounds. Biochem. Pharmacol., 53, 921-926.
24. Sinha, R., Said, T.K. and Medina, D. (1996) Organic and inorganic selenium compounds inhibit mouse mammary cell growth in vitro by different cellular pathways. Cancer Lett., 107, 277-284.
25. Sinha, R. and Medina, D. (1997) Inhibition of cdk2 kinase activity by methylselenocysteine in synchronized mouse mammary epithelial tumor cells. Carcinogenesis, 18, 1541-1547.
26. Thompson, H.J, Strange, R. and Schedin, P.J. (1992) Apoptosis in the genesis and prevention of cancer. Cancer Epidemiol. Biomarkers Prev., 1, 597-602.
27. Lu, J., Kaeck, M., Jiang, C., Wilson, A.C. and Thompson, H.J. (1994) Selenite induction of DNA strand breaks and apoptosis in mouse leukemic L1210 cells. Biochem. Pharmacol., 47, 1531-1535.
28. Sinha, R., Ganther, H.E. and Medina, D. (1999) Methylseleninic acid, a novel selenium compound inhibits mouse mammary epithelial tumor cells in vitro. Proc. Am. Assoc. Cancer Res., 40, 360.
29. Ganther, H. (1974) Biochemistry of selenium. In Zingaro, R.A and Cooper, W.C. (eds) Selenium. Van Nostrand Reinhold, New York, NY, pp. 546-614.
30. Ganther, H. and Corcoran, C. (1969) Selenotrisulfides. II. Cross-linking of reduced pancreatic ribonuclease with selenium. Biochemistry, 8, 2957-2963.
31. 2+-dependent isozymes of protein kinase C. Arch. Biochem. Biophys., 348, 25-36.
32. Islam, F., Watanabe, Y., Morii, H. and Hayaishi, O. (1991) Inhibition of rat brain prostaglandin D synthase by inorganic selenocompounds. Arch. Biochem. Biophys., 289, 161-166.
33. Spyrou, G., Bjornstedt, M., Kumar, S. and Holmgren, A. (1995) AP-1 DNA-binding activity is inhibited by selenite and selenodiglutathione. FEBS Lett., 368, 59-63.
34. Kim, I.Y and Stadtman, T.C. (1997) Inhibition of NF-kB DNA binding and nitric oxide induction in human T cells and lung adenocarcinoma cells by selenite treatment. Proc. Natl Acad. Sci. USA, 94, 12904-12907.
35. Ren, X., Bjornstedt, M., Shen, B., Ericson, M.L. and Holmgren, A. (1993) Mutagenesis of structural half-cystine residues in human thioredoxin and effects on the regulation of activity by selenodiglutathione. Biochemistry, 32, 9701-9708.
36. Lundstrom, J., Krause, G. and Holmgren, A. (1992) A Pro to His mutation in active site of thioredoxin increases its disulfide-isomerase activity 10-fold. New refolding systems for reduced or randomly oxidized ribonuclease. J. Biol. Chem., 267, 9047-9052.
37. Petronilli, V.P., Costantini, P., Scorrano, L., Colonna, R., Passamonti, S. and Bernardi, P. (1994) The voltage sensor of the mitochondrial permeability transition pore is tuned by the oxidation-reduction state of vicinal thiols. J. Biol. Chem., 269, 16638-16642.
38. Makropoulos, V., Bruning, T. and Schulze-Osthoff, K. (1996) Selenium-mediated inhibition of transcription factor NF-kB and HIV-1 LTR promoter activity. Arch. Toxicol., 70, 277-283.
39. Medina, D. and Lane, H.W. (1983) Stage specificity of selenium-mediated inhibition of mouse mammary tumorigenesis. Biol. Trace Elem. Res., 5, 297-306.
40. Medina, D. (1986) Mechanisms of selenium inhibition of tumorigenesis. J. Am. Coll. Toxicol., 5, 21-26.
41. Demple, B. (1998) A bridge to control. Science, 279, 1655-1656.
42. Zheng, M., Aslund, F. and Storz, G. (1998) Activation of the OxyR transcription factor by reversible disulfide bond formation. Science, 279, 1718-1721.
43. Clayton, C.C. and Baumann, C.A. (1949) Diet and azo dye tumors: effect of diet during period when the dye is not fed. Cancer Res., 9, 575-592.
44. Rotruck, J.T., Pope, A.L., Ganther, H.E., Swanson, A.B., Hafeman, D.G. and Hoekstra, W.G. (1973) Selenium: biochemical role as a component of glutathione peroxidase. Science, 179, 588-590.
45. Yang, J.-G., Hill, K.E. and Burk, R.F. (1989) Dietary selenium intake controls rat plasma selenoprotein P concentration. J. Nutr., 119, 1010-1012.
46. Behne, D., Kyriakoplulos, A., Gessner, H., Walzog, B. and Meinhold, H. (1992) Type I iodothyronine deiodinase activity after high selenium intake and relations between selenium and iodine metabolism in rats. J. Nutr., 122, 1542-1546.
47. Ip, C. and Ganther, H.E. (1992) Relationship between the chemical form of selenium and anticarcinogenic activity. In Watterberg, L., Lipkin, M., Boone, C.W. and Kelloff, G.J. (eds) Cancer Chemoprevention. CRC Press, Boca Raton, FL, pp. 479-488.
48. Danielson, K.G. and Medina, D. (1986) Distribution of selenoproteins in mouse mammary epithelial cells in vitro and in vivo. Cancer Res., 46, 4582-4589.
49. Morrison, D.G., Dishart, M.K. and Medina, D. (1988) Intracellular 58-kd selenoprotein levels correlate with inhibition of DNA synthesis in mammary epithelial cells. Carcinogenesis, 9, 1801-1810.
50. Sinha, R., Bansal, M.P., Ganther, H. and Medina, D. (1993) Significance of selenium-labeled proteins for selenium's chemopreventive functions. Carcinogenesis, 14, 1895-1900.
51. Tamura, T. and Stadtman, T.C. (1996) A new selenoprotein from human lung adenocarcinoma cells: purification, properties and thioredoxin reductase activity. Proc. Natl Acad. Sci. USA, 93, 1006-1011.
52. Gromer, S., Schirmer, R.H. and Becker, K. (1997) The 58 kDa mouse selenoprotein is a BCNU-sensitive thioredoxin reductase. FEBS Lett., 412, 318-320.
53. Morrison, D.G., Berdan, R.C., Pauly, D.F., Turner, D.S., Oborn, C.J. and Medina, D. (1988) Selenium distribution in mammary epithelial cells reveals its possible mechanism of inhibition of cell growth. Anticancer Res., 8, 51-64.
54. Liu, S.-Y. and Stadtman, T.C. (1997) Heparin-binding properties of selenium-containing thioredoxin reductase from HeLa cells and human lung adenocarcinoma cells. Proc. Natl Acad. Sci. USA, 94, 6138-6141.
55. Nordberg, J., Shong, L., Holmgren, A. and Arner, E.S.J. (1998) Mammalian thioredoxin reductase is irreversibly inhibited by dinitrohalobenzenes by alkylation of both the redox active selenocysteine and its neighboring cysteine residue. J. Biol. Chem., 273, 10835-10842.
56. Arscott, L.D., Gromer, S., Schirmer, R.H., Becker, K. and Williams, C.H. Jr (1997) The mechanism of thioredoxin reductase from human placenta is similar to the mechanisms of lipoamide dehydrogenase and glutathione reductase and is distinct from the mechanism of thioredoxin reductase from Escherichia coli. Proc. Natl Acad. Sci. USA, 94, 3621-3626.
57. Gorlatov, S.N. and Stadtman, T.C. (1998) Human thioredoxin reductase from HeLa cells: selective alkylation of selenocysteine in the protein inhibits enzyme activity and reduction with NADPH influences affinity to heparin. Proc. Natl Acad. Sci. USA, 95, 8520-8525.
58. Zhong, L., Arner, E.S.J., Ljung, J., Aslund, F. and Holmgren, A. (1998) Rat and calf thioredoxin reductase are homologous to glutathione reductase with a carboxy-terminal elongation containing a conserved catalytically active penultimate selenocysteine residue. J. Biol. Chem., 273, 8581-8591.
59. Gromer, S., Arscott, L.D., Williams, C.H. Jr, Schirmer, R.H. and Becker, K. (1998) Human placenta thioredoxin reductase. Isolation of the selenoenzyme, steady state kinetics and inhibition by therapeutic gold compounds. J. Biol. Chem., 273, 20096-20101.
60. Gladyshev, V.N., Sun, Q.-A., Wu, Y.L., Zappacosta, F., Jeang, K.-T., Lee, B.J. and Hatfield, D.L. (1999) Redox regulation of cell signaling by selenocysteine in mammalian thioredoxin reductases. FASEB J., 13, A1579.
61. Hill, K.E., McCollum, G.W. and Burk, R.F. (1997) Determination of thioredoxin reductase activity in rat liver supernatant. Anal. Biochem., 253, 123-125.
62. Hill, K.E., McCollum, G.W., Boeglin, M.E. and Burk, R.F. (1997) Thioredoxin reductase activity is decreased by selenium deficiency. Biochem. Biophys Res. Commun., 234, 293-295.
63. Kumar, S., Bjornstedt, M. and Holmgren, A. (1992) Selenite is a substrate for calf thymus thioredoxin reductase and thioredoxin and elicits a large non-stoichiometric oxidation of NADPH in the presence of oxygen. Eur. J. Biochem., 207, 435-439.
64. Berggren, M., Gallegosm, A., Gasdaskam, J. and Powis, G. (1997) Cellular thioredoxin reductase activity is regulated by selenium. Anticancer Res., 17, 3377-3380.
65. Gallegos, A., Berggren, M., Gasdaska, J.R. and Powis, G. (1997) Mechanisms of the regulation of thioredoxin reductase activity in cancer cells by the chemopreventive agent selenium. Cancer Res., 57, 4965-4970.
66. Berggren, M.M., Mangin, J.F., Gasdaska, J.R. and Powis, G. (1998) Effect of selenium on rat thioredoxin reductase activity. Biochem. Pharmacol., 57, 187-193.
67. Powis, G. (1998) Thioredoxin redox control of cell growth and death and the effects of inhibitors. Chem. Biol. Interact., 111/112, 23-24.
68. Kirkpatrick, D.L., Kuperus, M., Dowdeswell, M., Potier, N., Donald, L.J., Kunkel, M., Berggren, M., Angulo, M. and Powis, G. (1998) Mechanisms of inhibition of the thioredoxin growth factor system by antitumor 2-imidazolyl disulfides. Biochem. Pharmacol., 55, 987-994.
69. Gladyshev, V.N., Factor, V.M., Housseau, F. and Hatfield, D.L. (1998) Contrasting patterns of regulation of the antioxidant selenoproteins, thioredoxin reductase and glutathione peroxidase, in cancer cells. Biochem. Biophys Res. Commun., 251, 488-493.
70. Besse, D., Siedler, F., Dierks, T., Kessler, H. and Moroder, L. (1997) The redox potential of selenocysteine in unconstrained cyclic peptides. Angew. Chem. Int. Ed. Engl., 36, 883-805.
71. 2-thioredoxin. Biochemistry, 33, 3404-3412.
72. 7]-endothelin-1. J. Mol. Biol., 284, 779-792.
73. Burk, R.F. (1983) Biological activity of selenium. Annu. Rev. Nutr., 3, 53-70.
74. Reiter, R. and Wendel, A. (1983) Selenium and drug metabolism. I. Multiple modulations of mouse liver enzymes. Biochem. Pharmacol., 32, 3063-3067.
75. Reiter, R. and Wendel, A. (1984) Selenium and drug metabolism. II. Independence of glutathione peroxidase and reversibility of hepatic enzyme modulations in deficient mice. Biochem. Pharmacol., 33, 1923-1928.
76. Wendel, A. and Otter, R. (1987) Alterations in the intermediary metabolism of selenium-deficient mice. Biochim. Biophys. Acta, 925, 94-100.
77. Weitzel, F. and Wendel, A. (1993) Selenoenzymes regulate the activity of leukocyte 5-lipoxygenase via the peroxide tone. J. Biol. Chem., 268, 6288-6292.
78. Pleasants, J.C., Guo, W. and Rabenstein, D.L. (1989) A comparative study of the kinetics of selenol/diselenide and thiol/disulfide exchange reactions. J. Am. Chem. Soc., 11, 6553-6557.
79. Singh, R. and Whitesides, G.M. (1991) Selenols catalyze the interchange reactions of dithiols and disulfides in water. J. Org. Chem., 56, 6931-6933.
80. Singh, R. and Kats, L. (1995) Catalysis of reduction of disulfide by selenol. Anal. Biochem., 232, 86-91.
81. Bandyopadhyay, S., Starke, D.W., Mieyal, J.J. and Gronostajski, R.M. (1998) Thioltransferase (glutaredoxin) reactivates the DNA-binding activity of oxidation-inactivated nuclear factor I. J. Biol. Chem., 273, 392-397.
82. Yang, Y., Jao, S.-C., Nanduri, S., Starke, D.W., Mieyal, J.J. and Qin, J. (1998) Reactivity of the human thioltransferase (glutaredoxin) C7S, C25S, C78S, C8S mutant and NMR solution structure of its glutathionyl mixed disulfide intermediate reflect catalytic specificity. Biochemistry, 37, 17145-17156.
83. Bhattacharya, S.K., Ramchandani, S., Cervoni, N. and Szyf, M. (1999) A mammalian protein with specific demethylase activity for mCpG DNA. Nature, 397, 579-583.
84. Reich, H.J. and Cohen, M.L. (1979) Organoselenium chemistry. Dealkylation of amines with benzeneselenol. J. Org. Chem., 44, 3148-3151.
85. Jacob, C., Maret, W. and Vallee, B.L. (1999) Selenium redox biochemistry of zinc-sulfur coordination sites in proteins and enzymes. Proc. Natl Acad. Sci. USA, 96, 1910-1914.
86. Ip, C., Lisk, D.J. and Ganther, H.E. (1998) Activities of structurally-related lipophilic selenium compounds as cancer chemopreventive agents. Anticancer Res., 18, 4019-4026.